Close

Canaccord Genuity Reiterates a 'Hold' on Vertex (VRTX); Continued View of Challenging Out-Year Competitive Landscape Nov 21, 2011 08:40AM
Canaccord Genuity Maintains a 'Hold' on Vertex (VRTX); Cutting Q4 and Out-Year Incivek Estimates Nov 14, 2011 08:56AM
Canaccord Genuity Maintains a 'Hold' on Vertex (VRTX); Incivek Sales Peaking Oct 28, 2011 10:05AM
Canaccord Genuity Q3 Biotech Results Preview Oct 25, 2011 11:47AM
Canaccord Genuity Reiterates a 'Hold' on Vertex Pharma (VRTX); Q2 Preview Jul 27, 2011 09:44AM


Jul 6, 2011 08:30AM Canaccord Genuity Assumes Coverage on Vertex (VRTX) at Hold; Shares Fairly Valued
Mar 8, 2011 10:22AM Canaccord Genuity Morning Coffee on Pharmasset (VRUS): Great News for Hollywood
Feb 4, 2011 09:22AM Canaccord Genuity Maintains a 'Hold' on Vertex (VRTX); Q4/10: Likely Telaprevir Launch and Advancing Pipeline Make 2011 a Pivotal Yr
Dec 22, 2010 11:11AM Canaccord Genuity Reiterates a 'Hold' on Vertex (VRTX); Telaprevir + VX-222, IFN-free Combo Faces Another Challenge in All-Oral Quest
Dec 10, 2010 11:00AM Notable Analyst Rating Changes 12/10: PG, DRYS, LULU, COF Upgraded; CML, KOG, COG, VIA-B Downgraded
Nov 2, 2010 03:51PM Canaccord Genuity Reiterates a 'Hold' on Vertex Pharmaceuticals (VRTX); Telaprevir Maintains Edge Over Boceprevir; More Data To Come
Oct 26, 2010 01:30PM Canaccord Genuity reiterates a 'Hold' on Vertex Pharmaceuticals (VRTX); Q3/10: Near-term Focus on Telaprevir Data at AASLD